Erdmann E - Search Results

1

Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.

Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann E. Schneider CA, et al. Among authors: erdmann e. J Am Soc Nephrol. 2008 Jan;19(1):182-7. doi: 10.1681/ASN.2007060678. Epub 2007 Dec 5. J Am Soc Nephrol. 2008. PMID: 18057215 Free PMC article. Clinical Trial.

2

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive Investigators. Erdmann E, et al. Diabetes Care. 2007 Nov;30(11):2773-8. doi: 10.2337/dc07-0717. Epub 2007 Jul 31. Diabetes Care. 2007. PMID: 17666462 Clinical Trial.

3

[Diabetes and heart failure].

Schneider CA, Pfister R, Erdmann E. Schneider CA, et al. Among authors: erdmann e. Herz. 2010 May;35(3):140-6. doi: 10.1007/s00059-010-3337-z. Herz. 2010. PMID: 20467926 German.

4

Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial.

Pfister R, Erdmann E, Schneider CA. Pfister R, et al. Among authors: erdmann e. J Atheroscler Thromb. 2011;18(1):65-71. doi: 10.5551/jat.6247. Epub 2010 Nov 13. J Atheroscler Thromb. 2011. PMID: 21088369 Free article.

5

A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA. Pfister R, et al. Among authors: erdmann e. Int J Cardiol. 2013 Jan 10;162(2):112-6. doi: 10.1016/j.ijcard.2011.05.056. Epub 2011 Jun 1. Int J Cardiol. 2013. PMID: 21636144 Clinical Trial.

6

[Secondary prevention of cardiovascular diseases].

Schneider CA, Erdmann E. Schneider CA, et al. Among authors: erdmann e. Internist (Berl). 2004 Jun;45 Suppl 1:S23-30. doi: 10.1007/s00108-004-1221-8. Internist (Berl). 2004. PMID: 15148584 German.

7

[Hyperglycemia and cardiovascular events].

Schneider CA, Gallwitz B, Hanefeld M, Leschke M, Müller-Wieland D, Zeymer U, Erdmann E. Schneider CA, et al. Among authors: erdmann e. Dtsch Med Wochenschr. 2004 Nov 19;129(47):2553-7. doi: 10.1055/s-2004-835301. Dtsch Med Wochenschr. 2004. PMID: 15543474 Review. German.

8

[Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].

Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA. Pfister R, et al. Among authors: erdmann e. Dtsch Med Wochenschr. 2008 Mar;133(12):564-9. doi: 10.1055/s-2008-1067282. Dtsch Med Wochenschr. 2008. PMID: 18335382 German.

9

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.

Ferrannini E, Betteridge DJ, Dormandy JA, Charbonnel B, Wilcox RG, Spanheimer R, Erdmann E, Defronzo RA, Laakso M. Ferrannini E, et al. Among authors: erdmann e. Diabetes Obes Metab. 2011 Aug;13(8):759-64. doi: 10.1111/j.1463-1326.2011.01404.x. Diabetes Obes Metab. 2011. PMID: 21457426 Clinical Trial.

10

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.

Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD. Doehner W, et al. Among authors: erdmann e. Int J Cardiol. 2012 Dec 15;162(1):20-6. doi: 10.1016/j.ijcard.2011.09.039. Epub 2011 Oct 29. Int J Cardiol. 2012. PMID: 22037349 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

716 results

Search Page